ORXOY Projected Dividend Yield
ADR (Sponsored)/Orexo AB ( OTCBB : ORXOY )Orexo is an integrated pharma company with commercial operations in the U.S. and research and development in Sweden. Co.'s focus is primarily on opioid dependence and pain. Co.'s product portfolio includes Zubsolv®, a product for the treatment of opioid dependence; Abstral®, a sublingual tablet for the treatment of breakthrough cancer pain in patients; and Edluar®, for the treatment of short-term insomnia. Co.'s development projects include OX124 and OX125, both for treatment of opiod overdose; OX338 to treat moderate to moderately severe pain; and OX-MPI, to treat microvascular disease. 21 YEAR PERFORMANCE RESULTS |
ORXOY Dividend History Detail ORXOY Dividend News ORXOY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |